Moolec Science SA

MLEC Healthcare Biotechnology

Moolec Science SA’s revenue for fiscal 2025 (year ended June 2025) was $333.6 million, up 5,830.7% from fiscal 2024.

Revenue
+948.4%
EPS
−20.0%
Free cash flow
+4.48%

Quarter to December 2025, against a year earlier

0.85 0.00 0.00%
Market cap
$620.0K
P/E
0.0×
Fwd P/E
−2.5×
Dividend yield
—
F-score
4/9
Altman Z
−1.92
Beneish M
89.08
Dividend safety
0/100
Older periods Jun '24 Sep '24 Dec '24 Dec '25
ROE

+8 more TTM periods

(5.62%) (104.72%) (174.68%) 0.00%
ROA
(1.50%) (27.74%) (31.42%) 0.00%
ROIC
1.90% 50.68% 52.66% 0.00%
Return on Tangible Assets
(8.56%) (151.76%) (190.36%) 0.00%
Average Days of Receivables
15,853.22 108.79 127.61 0.00
Free Cash Flow per Share
57.99 72.73 69.80 0.00
Free Cash Flow
14.70 18.76 18.14 18.34
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026